1. Home
  2. Labeler Index
  3. Sagent Pharmaceuticals
  4. 25021-115
  5. NDC Package Code: 25021-115-04 Clindamycin

NDC Package 25021-115-04 Clindamycin

Clindamycin Phosphate Injection, Solution Intramuscular; Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
25021-115-04
Package Description:
25 VIAL in 1 CARTON / 4 mL in 1 VIAL
Product Code:
25021-115
Proprietary Name:
Clindamycin
Non-Proprietary Name:
Clindamycin Phosphate
Substance Name:
Clindamycin Phosphate
Usage Information:
This medication is used to treat a certain type of vaginal infection (bacterial vaginosis) in women who are not pregnant. Clindamycin is an antibiotic which works by stopping the growth of bacteria.
11-Digit NDC Billing Format:
25021011504
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1737244 - clindamycin 300 MG in 2 ML Injection
  • RxCUI: 1737244 - 2 ML clindamycin 150 MG/ML Injection
  • RxCUI: 1737244 - clindamycin (as clindamycin phosphate) 300 MG per 2 ML Injection
  • RxCUI: 1737244 - clindamycin 300 MG per 2 ML Injection
  • RxCUI: 1737578 - clindamycin 600 MG in 4 ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Sagent Pharmaceuticals
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • CLINDAMYCIN PHOSPHATE 150 mg/mL
  • CLINDAMYCIN PHOSPHATE 150 mg/mL
    • Pharmacologic Class(es):
  • Decreased Sebaceous Gland Activity - [PE] (Physiologic Effect)
  • Lincosamide Antibacterial - [EPC] (Established Pharmacologic Class)
  • Lincosamides - [CS]
  • Neuromuscular Blockade - [PE] (Physiologic Effect)
  • Decreased Sebaceous Gland Activity - [PE] (Physiologic Effect)
  • Lincosamide Antibacterial - [EPC] (Established Pharmacologic Class)
  • Lincosamides - [CS]
  • Neuromuscular Blockade - [PE] (Physiologic Effect)
    • Sample Package:
    No
    FDA Application Number:
    ANDA090108
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    05-15-2012
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 25021-115-04 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    25021011504J0736Inj, clindamycin phosp 300mg300 MG425250

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    25021-115-0225 VIAL in 1 CARTON / 2 mL in 1 VIAL
    25021-115-0625 VIAL in 1 CARTON / 6 mL in 1 VIAL
    25021-115-511 BOTTLE in 1 CARTON / 60 mL in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 25021-115-04?

    The NDC Packaged Code 25021-115-04 is assigned to a package of 25 vial in 1 carton / 4 ml in 1 vial of Clindamycin, a human prescription drug labeled by Sagent Pharmaceuticals. The product's dosage form is injection, solution and is administered via intramuscular; intravenous form.

    Is NDC 25021-115 included in the NDC Directory?

    Yes, Clindamycin with product code 25021-115 is active and included in the NDC Directory. The product was first marketed by Sagent Pharmaceuticals on May 15, 2012 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 25021-115-04?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 25021-115-04?

    The 11-digit format is 25021011504. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-225021-115-045-4-225021-0115-04